Nanobacteria: A Possible Etiology for Type III Prostatitis

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 364-369

  Shen, Xuecheng ^a   Ming, Aimin ^a   Li, Xin ^a   Zhou, Zhansong ^a   Song, Bo ^a  

^a SOUTHWEST HOSPITAL   (China)

Author keywords

calculi; chronic prostatitis; nanoparticles; prostate; prostatitis; rat, Sprague Dawley

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; MALE; NANOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROSTATITIS; PROSTATITIS TYPE III; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIA; CHI-SQUARE DISTRIBUTION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1BETA; MALE; NANOPARTICLES; PROSTATITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953123550     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.003     Document Type: Article

References (28)

1. Rodrguez F.M., Palou J., Tur A.B., et al. Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol 31 (2005) 1
2. Wood H.M., and Shoskes D.A. The role of nanobacteria in urologic disease. World J Urol 24 (2006) 51
3. Ciftcioglu N., Kuronen I., Akerman K., et al. A new potential threat in antigen and antibody products: nanobacteria. In: Brown F. (Ed). Vaccines 97 (1997), Cold Spring Harbor Laboratory Press, New York 99-103
4. Jones JA, Carlson D, Shoskes D et al: Association of calcifying nanoparticles within serum and prostates of patients with prostatic inflammation and hyperplasia: a preliminary analysis. Presented at annual meeting of Society for Infection and Inflammation in Urology, San Antonio, Texas, May 22, 2005.
5. Zhou Z., Hong L., Shen X., et al. Detection of nanobacteria infection in type III prostatitis. Urology 71 (2008) 1091
6. Shoskes D.A., Thomas K.D., and Gomez E. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 173 (2005) 474
7. Ciftçioglu N., and Kajander E.O. Interaction of nanobacteria with cultured mammalian cells. Physiopathology 4 (1998) 259
8. Shiekh F.A., Khullar M., and Singh S.K. Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 34 (2006) 53
9. Akerman K.K., Kuikka J.T., Ciftcioglu N., et al. Radiolabeling and in vivo distribution of nanobacteria in the rabbit. Proc SPIE Int Soc Opt Eng 3111 (1997) 436
10. Wang L., Shen W., Wen J., et al. An animal model of black pigment gallstones caused by nanobacteria. Dig Dis Sci 51 (2006) 1126
11. Cuerpo G.E., Kajander E.O., Ciftçioglu N., et al. Nanobacteria: an experimental neo-lithogenesis model. Arch Esp Urol 53 (2000) 291
12. Bock E., Calugi V., Stolfi C., et al. Calcifications of the prostate: a transrectal echographic study. Radiol Med 77 (1989) 501
13. Geramoutsos I., Gyftopoulos K., Perimenis P., et al. Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 45 (2004) 333
14. Torres R.C., Aguilar R.J., Zuluaga G.A., et al. Ultrastructure of primary or endogenous prostatic calculi. Scanning electronmicroscopic study. Arch Esp Urol 34 (1981) 13
15. Ciftçioglu N., Bjorklund M., Kuorikoski K., et al. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56 (1999) 1893
16. Nickel J.C., Olson M.E., Barabas A., et al. Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol 66 (1990) 47
17. Kajander E.O., and Ciftçioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95 (1998) 8274
18. Barbalias G.A., Nikiforidis G., and Liatsikos E.N. A-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 159 (1998) 883
19. Barbalias G.A. Clinical and therapeutical guidelines for chronic prostatitis, from bacteriological importance to neuromuscular considerations. Eur Urol 34 (1998) 457
20. Barbalias G.A. Prostatodynia or painful male urethral syndrome?. Urology 36 (1990) 146
21. Hjelle J.T., Miller-Hjelle M.A., Poxton I.R., et al. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57 (2000) 2360
22. Jang T.L., and Schaeffer A.J. The role of cytokines in prostatitis. World J Urol 21 (2003) 95
23. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503
24. Raeburn C.D., Sheppard F., Barsness K.A., et al. Cytokines for surgeons. Am J Surg 183 (2002) 268
25. Nadler R.B., Koch A.E., Calhoun E.A., et al. IL-1β and TNF-α in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 164 (2000) 214
26. Anderson H.C. Mechanisms of pathologic calcification. Rheum Dis Clin North Am 14 (1988) 303
27. Wiessner J.H., Hasegawa A.T., Hung L.Y., et al. Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59 (2001) 637
28. Ciftcioglu N., Hjelle M.A., Hjelle J.T., et al. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46 (2002) 2077